Bristol-Myers Squibb Co. Resources | BNET

BNET Industries

Bristol-Myers Squibb Co. (BMY) is in the Pharma Industry

Revenue
Dec 31 2007
$19.3B
Profit
Dec 31 2007
$2.1B
Market Cap
Jul 23 2008
$43.3B

Latest News and Analysis

Additional Resources

  • page 1 of 181
  • Incorporated: 1933
  • CEO: Mr. James M. Cornelius

Bristol-Myers Squibb is a biopharmaceutical and related health care products company. Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and related health care products. As of Dec 31 2007, Co. had three reportable segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment consists of the global pharmaceutical/biotechnology and international consumer medicines business. The Nutritionals segment consists of Mead Johnson Nutritionals, primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of ostomy, wound and skin care business.

Key Competitors

Bristol-Myers Squibb Co. Company Info

Board of Directors

Mr. James M. Cornelius

Chairman

Dr. Robert Sanders Williams

Mr. Lewis B. Campbell

Lead Director

Mr. Louis J. Freeh

Dr. Laurie H. Glimcher M.D.

Mr. Michael Grobstein

Mr. Leif Johansson

Mr. Alan J. Lacy

Dr. Vicki L. Sato Ph.D.

Mr. Togo D. West Jr.

Contact Information

345 Park Avenue

New York, NY

http://www.bms.com

212 546-4000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412